iCell Gene Therapeutics

iCell Gene Therapeutics is a developer of gene therapy technologies aimed at targeting and destroying various types of cancer. The company's chimeric antigen receptor-engineered cells create new immunotherapies for cancer treatment, enter clinical studies targeting T-cell malignancies, eradicate devastating diseases, and provide cost-effective treatments for drug-resistant cancer patients.